Skip to main content
Canadian Family Physician logoLink to Canadian Family Physician
. 2024 Apr;70(4):249–253. doi: 10.46747/cfp.7004249

Assessment of urinary incontinence in older adults, part 1

William Gibson 1, Frank Molnar 2, Chris Frank 3
PMCID: PMC11280674  PMID: 38627001

Clinical question

How should I assess my older patient who has urinary incontinence (UI)?

Bottom line

Urinary incontinence, the involuntary loss of any urine,1 is a common problem among people older than 65 or those living with frailty but should not be considered part of “normal” aging. The cornerstones of assessment are comprehensive history, basic physical examination, and focused investigations. Urinary incontinence is a multifactorial geriatric syndrome, not necessarily a disorder of the lower urinary tract itself.2 A detailed review of this topic was published in 2015 in the Canadian Geriatrics Society Journal of CME.3

Evidence

  • Patients older than 65 living with frailty, particularly those living in institutional care settings, have among the highest rates of UI of any group other than people with spinal cord injury.4

  • Brain changes (eg, white matter hyperintensities) are implicated in the pathogenesis of UI.5 It is unclear whether midlife interventions such as blood pressure control can prevent the development of lower urinary tract symptoms (LUTS), including UI.

  • Urinary incontinence is associated with social isolation, depression, and falls.6-8

Approach

Clinical classification of type of incontinence is relevant:

Overactive bladder (OAB). Overactive bladder is urinary urgency, usually accompanied by daytime frequency or nocturia, not caused by urinary tract infection or other disease. Overactive bladder may cause incontinence (OAB wet) or not (OAB dry).9 It is not synonymous with detrusor overactivity, the finding of detrusor contractions during cystometry.1 The correlation between OAB and detrusor overactivity in older adults is poor and cystometry is not usually necessary.2

Stress urinary incontinence. Stress urinary incontinence is the involuntary loss of urine on effort or physical exertion, or with sneezing or coughing.1 Risk factors include genetics, parity, obesity, and smoking. Stress urinary incontinence is due to urethral sphincter incompetence or excessive mobility of pelvic floor musculature decreasing the support necessary to protect against fluctuations in intra-abdominal pressure. Stress incontinence is rare in men who have not had prostatectomy.

Functional incontinence. Continence requires an individual to recognize the need to void and to locate, get to, and use a toilet. Failure to maintain continence due to behavioural, cognitive, environmental, or disease-related factors is termed “functional” or “disability associated” incontinence.1 An older person who is restrained by bedrails, is unable to gain access to their mobility aid, or moves to a facility with inadequate signage to the toilets may lose continence even with normal lower urinary tract function.

Overflow incontinence. Although postvoid residual volume rises with normal aging, the level at which this rise becomes of pathologic importance is dictated by outcomes or consequences rather than by an arbitrary cutoff.10 Overflow incontinence can be seen in patients with chronic painless urinary retention, when the intravesical pressure can no longer be contained by the urethral sphincter, classically leading to frequent small-volume voids and dribbling incontinence.11

It is common for more than one type of incontinence to be present (most commonly urgency and stress incontinence). The predominant type in terms of impact should be noted in the patient’s medical record (eg, “urgency predominant mixed incontinence”).

Assessment should include reviewing the following:

  • lower urinary tract symptoms;

  • storage symptoms (ie, urgency, frequency, nocturia, stress incontinence);

  • voiding symptoms (eg, straining, slow stream, terminal dribble);

  • postmicturition symptoms (eg, feeling of incomplete emptying, postvoid dribbling);

  • comorbidities (Table 1)12,13;

  • medications (Table 2)12,13;

  • function and cognition;

  • self-management strategies (eg, fluid intake, pad use); and

  • impact on quality of life.

Table 1.

Factors that can cause or contribute to UI in older adults living with frailty

FACTORS COMMENTS IMPLICATIONS FOR MANAGEMENT
Diabetes mellitus Poor control can cause polyuria and precipitate or exacerbate incontinence; also associated with increased likelihood of urgency UI and diabetic neuropathic bladder Better control of diabetes can reduce osmotic diuresis and associated polyuria and improve UI
Degenerative joint disease Can impair mobility and precipitate urgency UI Optimal pharmacologic and nonpharmacologic pain management can improve mobility and toileting ability
Chronic pulmonary disease Associated cough can worsen stress UI Cough suppression can reduce stress incontinence and cough-induced urgency UI
Congestive heart failure, lower extremity venous insufficiency Increased nighttime urine production can contribute to nocturia and UI Optimizing pharmacologic management of congestive heart failure, sodium restriction, support stockings, leg elevation, and a late-afternoon dose of a rapid-acting diuretic may reduce nocturnal polyuria and associated nocturia and nighttime UI
Sleep apnea May increase nighttime urine production by increasing production of atrial natriuretic peptide Diagnosis and treatment of sleep apnea, usually with continuous positive airway pressure devices, may improve the condition and reduce nocturnal polyuria and associated nocturia and UI
Severe constipation and fecal impaction Associated with “double” incontinence (urinary and fecal)
  • Appropriate use of stool softeners

  • Adequate fluid intake and exercise

  • Disimpaction if necessary

Neurologic and psychiatric conditions
  • Stroke

Can precipitate urgency UI and less often urinary retention; also impairs mobility
  • UI after an acute stroke often resolves with rehabilitation; persistent UI should be further evaluated

  • Regular toileting assistance is essential for those with persistent mobility impairment

  • Optimizing management may improve mobility and improve UI

  • Parkinson disease

Associated with urgency UI; also causes impaired mobility and cognition in late stages Regular toileting assistance is essential for those with mobility and cognitive impairments in late stages
  • Normal pressure hydrocephalus

Presents with UI, along with gait and cognitive impairments Patients presenting with all 3 symptoms should be considered for brain imaging to rule out this condition, as it may improve with a ventricular-peritoneal shunt
  • Dementia (Alzheimer disease, multi-infarct, others)

Associated with urgency UI; impaired cognition and apraxia interfere with toileting and hygiene Regular toileting assistance is essential for those with mobility and cognitive impairment in late stages
  • Depression

May impair motivation to be continent; may also be a consequence of incontinence Optimizing pharmacologic management of depression may improve UI
Medications See Table 2 for more information12,13 Discontinuation or modification of drug regimen
Functional impairments
  • Impaired mobility

  • Impaired cognition

Impaired mobility or cognition due to a variety of conditions listed above and others can interfere with the ability to toilet independently and precipitate UI Regular toileting assistance is essential for those with severe mobility or cognitive impairment
Environmental factors
  • Inaccessible toilets

  • Unsafe toilet facilities

  • Unavailable caregivers for toileting assistance

Frail, functionally impaired persons require accessible, safe toilet facilities and in many cases human assistance to be continent Environmental alterations may be helpful; supportive measures such as pads may be necessary if caregiver assistance is not regularly available

UI—urinary incontinence.

Adapted with permission from the International Continence Society.13

Table 2.

Medications that may contribute to lower urinary tract symptoms and UI

MEDICATIONS EFFECTS ON CONTINENCE
α-Adrenergic agonists, including midodrine, clonidine, and phenylephrine Increase smooth muscle tone in urethra and prostatic capsule and may precipitate obstruction, urinary retention, and related symptoms
α-Adrenergic antagonists (α-blockers), such as doxazosin, alfuzosin, and tamsulosin Decrease smooth muscle tone in the urethra and may precipitate stress UI in women
Angiotensin-converting enzyme inhibitors Cause cough that can exacerbate UI
Anticholinergics (see Table 4 in Dyks and Sadowski12)
  • May cause impaired emptying, urinary retention, and constipation that can contribute to UI

  • May cause cognitive impairment and reduce effective toileting ability

Calcium channel blockers
  • May cause impaired emptying, urinary retention, and constipation that can contribute to UI

  • May cause dependent edema, which can contribute to nocturnal polyuria

Cholinesterase inhibitors Increase bladder contractility and may precipitate urgency UI
Diuretics Cause diuresis and precipitate UI
Lithium Polyuria due to diabetes insipidus
Opioid analgesics May cause urinary retention, constipation, confusion, and immobility, all of which can contribute to UI
Psychotropic drugs
  • Sedatives

  • Hypnotics

  • Antipsychotics

  • Histamine-1 receptor antagonists

  • May cause confusion and impaired mobility and precipitate UI

  • Anticholinergic effects

  • Confusion

Selective serotonin reuptake inhibitors Increase cholinergic transmission and may lead to UI
Sodium-glucose cotransporter-2 inhibitors Glycosuria and polyuria, increased propensity to urinary tract infection
Others
  • Gabapentin

  • Glitazones

  • Nonsteroidal anti-inflammatory agents

Can cause edema, which can lead to nocturnal polyuria and cause nocturia and nighttime UI

UI—urinary incontinence.

Adapted with permission from the International Continence Society.13

Box 1 summarizes causes of more acute and subacute incontinence.12-14

Box 1. Assessment of acute and subacute urinary incontinence: DIAPPERS mnemonic.

In patients presenting with new-onset urinary incontinence the following potential causes, with the mnemonic DIAPPERS,14 should be considered:

  • Delirium

  • Infection*

  • Atrophic vaginitis (genitourinary syndrome of menopause)

  • Pharmaceuticals (Table 2)12,13

  • Psychological

  • Excess urine output

  • Reduced mobility

  • Stool impaction

*Avoid treatment of asymptomatic bacteriuria.

Implementation

Up to half of patients with UI never seek assistance for their symptoms.15,16 Patients may fail to seek help because of embarrassment, a belief that UI is a normal part of aging, or a belief that UI is untreatable.17 It is imperative that health care professionals dealing with those at risk actively identify UI through focused questioning and assessment. Unfortunately, many clinicians contribute to the care gap because of limited confidence and preconceptions about the efficacy of treatments or by prioritizing other “more important” conditions.18 Validated case-finding tools have been employed in primary care practice, including the Bladder Control Self-assessment Questionnaire and the Overactive Bladder Validated 8-question questionnaire.19,20

The minimal examination includes abdominal examination for palpable bladder, assessment of external genitalia for abnormalities (eg, phimosis, incontinence-related dermatitis), and basic examination for urogenital atrophy and pelvic organ prolapse in women. A rectal examination should be done to exclude fecal loading and to assess the prostate in men. In patients with evidence of neurologic disease, a screening examination is important. An essential part of the evaluation is noting the patient’s physical and cognitive abilities to get to the toilet, undress, void, and wash and dress afterward.

A bedside dipstick urinalysis (for hematuria, glycosuria, or bacteriuria) should be performed. In addition, if there are voiding symptoms a postvoid residual volume should be recorded using a hand-held ultrasound device or in-and-out catheterization if ultrasound is not available.21 Catheterization is, of course, associated with a small risk of infection.

If the concern is of stress urinary incontinence, a lying or standing cough test can be done. To perform a standing cough test, ask the patient to stand and to cough; the test is positive if any degree of urine leakage occurs. The Q-tip test or other tests of urethral hypermobility are of limited usefulness and guidelines recommend against their use.21

In the majority of cases investigations such as an ultrasound scan of the lower urinary tract, laboratory tests, or cystometry are not required. The presence of bacteriuria in a patient with chronic LUTS is of controversial importance; if the urine dip or symptoms suggests bacteriuria, a midstream urine sample should be sent for analysis and appropriate antibiotics should be prescribed based on the culture result. If LUTS are unaffected, a repeat prescription of antibiotics is not justified. For a more detailed review of this topic please see the previously mentioned article published in the Canadian Geriatrics Society Journal of CME.3

Geriatric Gems are produced in association with the Canadian Geriatrics Society Journal of CME, a free peer-reviewed journal published by the Canadian Geriatrics Society (http://www.geriatricsjournal.ca). The articles summarize evidence from review articles published in the Canadian Geriatrics Society Journal of CME and offer practical approaches for family physicians caring for elderly patients.

Footnotes

Competing interests

Dr William Gibson has received speaker honoraria from Astellas and Pfizer.

References

  • 1.D’Ancona C, Haylen B, Oelke M, Abranches-Monteiro L, Arnold E, Goldman H, et al. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn 2019;38(2):433-77. Epub 2019 Jan 25. [DOI] [PubMed] [Google Scholar]
  • 2.Gibson W, Johnson T, Kirschner-Hermanns R, Kuchel G, Markland A, Orme S, et al. Incontinence in frail elderly persons: report of the 6th International Consultation on Incontinence. Neurourol Urodyn 2020;40(1):38-54. Epub 2020 Oct 21. [DOI] [PubMed] [Google Scholar]
  • 3.Gibson W, Wagg A.. Urinary incontinence in the frail elderly. Can Geriatr Soc J CME 2015;5(2). [Google Scholar]
  • 4.Batmani S, Jalali R, Mohammadi M, Bokaee S.. Prevalence and factors related to urinary incontinence in older adults women worldwide: a comprehensive systematic review and meta-analysis of observational studies. BMC Geriatr 2021;21(1):212. Erratum in: BMC Geriatr 2022;22(1): 454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Sakakibara R, Panicker J, Fowler CJ, Tateno F, Kishi M, Tsuyusaki Y, et al. Is overactive bladder a brain disease? The pathophysiological role of cerebral white matter in the elderly. Int J Urol 2014;21(1):33-8. Epub 2013 Sep 30. [DOI] [PubMed] [Google Scholar]
  • 6.Lai HH, Rawal A, Shen B, Vetter J.. The relationship between anxiety and overactive bladder or urinary incontinence symptoms in the clinical population. Urology 2016;98:50-7. Epub 2016 Jul 19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Luo X, Chuang CC, Yang E, Zou KH, Araiza AL, Bhagnani T.. Prevalence, management and outcomes of medically complex vulnerable elderly patients with urinary incontinence in the United States. Int J Clin Pract 2015;69(12):1517-24. Epub 2015 Sep 9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Brown JS, Vittinghoff E, Wyman JF, Stone KL, Nevitt MC, Ensrud KE, et al. Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc 2000;48(7):721-5. [DOI] [PubMed] [Google Scholar]
  • 9.Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010;29(1):4-20. [DOI] [PubMed] [Google Scholar]
  • 10.Malde S, Belal M, Mohamed-Ahmed R, Gibson W, Padilla-Fernandez B, Rantell A, et al. Can we define the optimal postvoid residual volume at which intermittent catheterization should be recommended, and are there other measures that could guide an intermittent catheterization protocol: ICI-RS 2023. Neurourol Urodyn 2023. Oct 31. Epub ahead of print. [DOI] [PubMed] [Google Scholar]
  • 11.Stoffel JT, Peterson AC, Sandhu JS, Suskind AM, Wei JT, Lightner DJ.. AUA white paper on nonneurogenic chronic urinary retention: consensus definition, treatment algorithm, and outcome end points. J Urol 2017;198(1):153-60. Epub 2017 Feb 3. [DOI] [PubMed] [Google Scholar]
  • 12.Dyks D, Sadowski CA.. Interventions to reduce medication-related falls. Can Geriatr Soc J CME 2015;5(1):23-31. [Google Scholar]
  • 13.Wagg A, Bower W, Gibson W, Kirschner-Hermanns R, Hunter K, Kuchel G, et al. Incontinence in frail older adults. In: Cardozo L, Rovner E, Wagg A, Wein A, Abrams P, editors. Incontinence. 7th ed. Bristol, UK: International Continence Society; 2023. p. 1463-572. [Google Scholar]
  • 14.Resnick NM, Yalla SV.. Management of urinary incontinence in the elderly. N Engl J Med 1985;313(13):800-5. [DOI] [PubMed] [Google Scholar]
  • 15.Teunissen D, van Weel C, Lagro-Janssen T.. Urinary incontinence in older people living in the community: examining help-seeking behaviour. Br J Gen Pract 2005;55(519):776-82. [PMC free article] [PubMed] [Google Scholar]
  • 16.Elstad EA, Taubenberger SP, Botelho EM, Tennstedt SL.. Beyond incontinence: the stigma of other urinary symptoms. J Adv Nurs 2010;66(11):2460-70. Epub 2010 Aug 23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Shaw C, Tansey R, Jackson C, Hyde C, Allan R.. Barriers to help seeking in people with urinary symptoms. Fam Pract 2001;18(1):48-52. [DOI] [PubMed] [Google Scholar]
  • 18.Albers-Heitner P, Berghmans B, Nieman F, Lagro-Janssen T, Winkens R.. Adherence to professional guidelines for patients with urinary incontinence by general practitioners: a cross-sectional study. J Eval Clin Pract 2008;14(5):807-11. Epub 2008 May 2. [DOI] [PubMed] [Google Scholar]
  • 19.Basra R, Artibani W, Cardozo L, Castro-Diaz D, Chapple C, Cortes E, et al. Design and validation of a new screening instrument for lower urinary tract dysfunction: the Bladder Control Self-assessment Questionnaire (B-SAQ). Eur Urol 2007;52(1):230-7. Epub 2006 Nov 15. [DOI] [PubMed] [Google Scholar]
  • 20.Peterson AC, Sehgal A, Crump RT, Baverstock R, Sutherland JM, Carlson K.. Evaluating the 8-item overactive bladder questionnaire (OAB-v8) using item response theory. Neurourol Urodyn 2018;37(3):1095-100. Epub 2017 Oct 4. [DOI] [PubMed] [Google Scholar]
  • 21.Urinary incontinence and pelvic organ prolapse in women: management. Manchester, UK: National Institute for Health and Care Excellence; 2019. Available from: https://www.nice.org.uk/guidance/ng123. Accessed 2024 Mar 15. [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES